retatrutide clinical trials results trial ⭐️topline results from TRIUMPH-1, a Phase 3 clinical trial evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon triple hormone receptor agonist, in adults with obesity or “overweight” Results from retatrutide clinical trials?

In addition, rising public awareness about weight management and cardiometabolic health is fueling further demand

Heres the reality: GLP-1 medications deliver 1520%+ weight loss, transform diabetes care, and have a strong, well-studied safety profile

Suspected counterfeit or unauthorized products can be reported to Health Canada through its health product complaint process [Source: recalls-rappels.canada.ca/en/alert-recall/thinking-about-buying-glp-1-drugs-ozempic-or-mounjaro-beware-fake-or-unauthorized]

However, GLP-1 strength training Chicago programs focus on preserving lean muscle while reducing fat

Rheumatology 64 , 35003508 (2025)

The most sustainable path is a balanced strategy: targeted eligibility, strong utilization management, integration with lifestyle programs, and thoughtful plan design